| TOP NUTRITION NEWSLETTER VOLUME 2, NO
3:MARCH 1999 Editorial
This is the third issue of TOP NUTRITION NEWSLETTER in
1999. In this issue enteral glutamine in trauma patients,
soy protein and lipd profiles, immunonutrition, and
nutrition recommendations for the person with diabetes
are updated for your interest.
Infections are the important cause of morbidity and
mortality in ICU patients. Aggressive nutritional support
has been applied to reduce the mortality but the rate has
not been reduced. Immunonutrients have been tried to
reduce the infections. Animals and human studies have
suggested that glutamine-enriched nutrition decreases the
number of infections."Randomised trial of
glutamine-enriched enteral nutrition on infectious
morbidity in patients with multiple trauma"
supported the concept and stimulated the further larger
studies.
Consumption of soy protein, rather than animal protein,
decreases serum cholesterol concentrations, but studies
in humans have been inconclusive. In this meta-analysis
of 38 controlled clinical trials, soy protein consumption
significantly decreases serum lipid concentrations in
humans. You can rely on this respectable medical journal
that accepted this original article of
"Meta-Analysis of the Effects of Soy Protein Intake
on Serum Lipids".
Editorial opinions in January 1999 issue of
"Nutrition" titled IMMUNONUTRITION-Concluding
Remarks is my choice this month as the author mentioned
almost second patient admitted to any hospital is either
malnourished or at risk of malnutrition.Due to
preservation of food, many Westerners suffer from latent
glutathione (GSH) deficiency. Many foods rich in
important nutrients (immunonutrients) are not eaten today
to the same extent as they were in the past.Why
immunonutrients should be included in critically ill
patients to minimize stress related immunosuppression is
an important issue in clinical nutrition.
ADA recommendation to limit saturated fats and dietary
cholesterol remains clear, the current direction to
adjust fat and carbohydrate (CHO) calories based on
individual weight, glycemic control, and lipid profile
presents a dlemma over how to best distribute CHO and
monounsaturated fatty acids (MUFA) in the daily diet.
This article "Nutrition recommendations for the
person with diabetes" will frame the discussion of
current US and European position statements on
macronutrient distribution for DM patients and review the
arguments for and against high-MUFA diets as part of
medical nutrition therapy and outline the dietary
guidelines.
Any comments or suggestions to include the interesting
topics are welcomed for future issues.
Dr Shwe Win
Editor
Randomised trial of
glutamine-enriched enteral nutrition on infectious
morbidity in patients with multiple trauma
Reference:Lancet 1998; 352: 772-76
Background:
Infections are an important cause of
morbidity and mortality in patients with multiple trauma.
Studies in both animals and human beings have suggested
that glutamine-enriched nutrition decreases the number of
infections.
Methods:
Patients with multiple trauma with an
expected survival of more than 48 h, and who had an
Injury Severity Score of 20 or more, were randomly
allocated glutamine-supplemented enteral nutrition or a
balanced, isonitrogenous, isocaloric enteral-feeding
regimen along with usual care. Each patient was assessed
every 8 h for infection, the primary endpoint. Data were
analysed both per protocol, which included enteral
feeding for at least 5 days, and by intention to treat.
Findings:
72 patients were enrolled and 60 received
enteral feeding (29 glutamine-supplemented) for at least
5 days. Five (17%) of 29 patients in the
glutamine-supplemented group had pneumonia compared with
14 (45%) of 31 patients in the control group (p<0.02).
Bacteraemia occurred in two (7%) patients in glutamine
group and 13 (42%) in the control group (p<0?005). One
patient in the glutamine group had sepsis compared with
eight (26%) patients in the control group (p<0.02).
Interpretation:
There was a low frequency of pneumonia,
sepsis, and bacteraemia in patients with multiple trauma
who received glutamine-supplemented enteral nutrition.
Larger studies are needed to investigate whether
glutamine-supplemented enteral nutrition reduces
mortality.
Meta-Analysis of the Effects of Soy
Protein Intake on Serum Lipids
Reference: N Engl J Med 1995;333:276-82.
Background. In laboratory animals, the
consumption of soy protein, rather than animal protein,
decreases serum cholesterol concentrations, but studies
in humans have been inconclusive. In this meta-analysis
of 38 controlled clinical trials, we examined the
relation between soy protein consumption and serum lipid
concentrations in humans.
Methods. We used a random-effects model to quantify the
average effects of soy protein intake on serum lipids in
the studies we examined and used hierarchical
mixed-effects regression models to predict variation as a
function of the characteristics of the studies.
Results. In most of the studies, the intake of energy,
fat, saturated fat, and cholesterol was similar when the
subjects ingested control and soy-containing diets; soy
protein intake averaged 47 g per day. Ingestion of soy
protein was associated with the following net changes in
serum lipid concentrations from the concentrations
reached with the control diet: total cholesterol, a
decrease of 23.2 mg per deciliter (0.60 mmol per liter;
95 percent confidence interval, 13.5 to 32.9 mg per
deciliter [0.35 to 0.85 mmol per liter]), or 9.3 percent;
low-density lipoprotein (LDL) cholesterol, a decrease of
21.7 mg per deciliter (0.56 mmol per liter; 95 percent
confidence interval, 11.2 to 31.7 mg per deciliter [0.30
to 0.82 mmol per liter]), or 12.9 percent; and
triglycerides, a decrease of 13.3 mg per deciliter (0.15
mmol per liter; 95 percent confidence interval, 0.3 to
25.7 mg per deciliter [0.003 to 0.29 mmol per liter]), or
10.5 percent. The changes in serum cholesterol and LDL
cholesterol concentrations were directly related to the
initial serum cholesterol concentration (P<0.001). The
ingestion of soy protein was associated with a
nonsignificant 2.4 percent increase in serum
concentrations of high-density lipoprotein (HDL)
cholesterol.
Conclusions. We found that the consumption of soy protein
rather than animal protein significantly decreased serum
concentrations of total cholesterol, LDL cholesterol, and
triglycerides.
Immunonutrition - Concluding Remarks
Reference: Nutrition 1999;15(1):57-61.
It has been sugested that the balance between TH1
lymphocytes, primarily associated with cellular immunity,
and TH2 lymphocytes, mainly associated with humoral
immunity, should be of special importnce to our health
and well being. Intake of L acidophilus is known to
result in a greater than 4-fold increase in IgA response.
It is unfortunate that direct immunologic
parameters are rarely studied in connection with surgical
operation and trauma, but several studies report a
reduced morbidity and mortality in patients receiving
early EN following trauma or surgery. Recently
significant changes in different immune parameters in
patients with severe acute pancreatitis were observed and
related to the mode of feeding. 5 out of 12 patients in
the parenteral group developed multiple organ failure
(MOF) in contrast to none among the enterally fed
patients.
Stimulation of the immune system of the gut
by enteral feeding in liver transplantation did reduce
hospital stay and mortality by one-third compared with
traditional intravenous feeding. But most interesting,
the early rejection (30d) rate fell from 44% to 7%. It
seems evident that up-regulation of the gut-associated
lymphoid tissue (GALT) system is an important adjunct to
pharmaceutical immunosuppression.
Undoubtedly, it will take a considerable
amount of time and effort to change opinions and practice
toward a more liberal EN policy: to accept larger initial
amounts, to use more fresh foods, and to maintain an
uninterrupted supply. Proper EN is not only much cheaper
than PN, but will also lead to substantial savings by
reducing the length of hospital stays and the use of
pharmaceuticals that are not only expensive, but also
often responsible for adverse effects, including unwanted
immunosuppression.

Nutrition
recommendations for the person with diabetes
Reference: Clinical Nutrition 1998;17(S2):18-25.
Current recommendations for
macronutrient distribution
| Nutrient |
Unit |
BDA -1992 |
NCEP II- 1994 |
ADA -1994 |
EASD-1995 |
ALFEDIAM 1996 |
| Protein |
% energy |
10-15 |
± 15 |
10-20 |
10-20 |
10-20 |
| Fat |
% energy |
30-35 |
<30 |
80-90 for CHO+total fat; 60-70 for
CHO+MUFA |
<30 (in energy -restricted diet) |
30-40 (individually tailored) |
| SFA |
% energy |
<10 |
8-10 |
<10 |
<10 |
<10 |
| MUFA |
% energy |
10-15 |
</=15 |
60-70 for CHO+MUFA |
Ratio of MUFA & CHO individually
tailored |
10-20 |
| PUFA |
% energy |
10 |
</=10 |
</=10 |
</=10 |
±10 |
| Cholesterol |
mg/d |
</=300 |
</=300 |
</=300 |
<300 |
<300 |
| CHO |
% energy |
50-55 |
>/=55 |
80-90 for CHO + fat |
Ratio of MUFA & CHO individually
tailored |
45-55 individually tailored |
| Mono/Di saccharides |
|
foods high in fibre or resistant
starch |
|
|
Foods with lower glycemic index or
rich in soluble fiber |
Foods with lower glycemic index |
| Sucrose |
% energy |
</=25 g/d |
|
no restrictions |
<10 |
<10 |
| Fructose |
|
|
|
no recommendations |
use not encouraged |
|
| Complex CHO |
|
preferred |
|
no recommendations |
|
preferred |
The CHO /
MUFA dilemma
(1)Optimal CHO/MUFA
distribution suggests a broader applicability of the
high-MUFA diet to both type 1 and type 2 diabetes.
(2)European
community recommends limiting the addition of simple
sugars (sucrose to <10% of total daily calories, or
sucrose plus fructose to </=25 g/day.ADA discourages
resistriction of sugars.
| DATA IN
SUPPORT OF HIGH-MUFA DIETS |
CONCERNS
ABOUT HIGH-MUFA DIETS |
| Improved
glycemic control |
Cardiovascular
risk factors (atherosclerosis,obesity) |
| Normalization
of serum lipids |
Cancer risk |
| Protective effects on
the arterial walls |
Public confusion about
nutrition guidelines |
| Improved patient
compliance |
|
|